• Register
  • Login
  • Subscribe
  • Contact Us

Latest Vaccine Tenders in Chile 2026

ChileTenders brings you the latest and most relevant Vaccine tenders in Chile, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Vaccine and other products and services tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to ChileTenders, users gain unlimited access to public procurement notices related to Vaccine. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Chile.

Pancreolipasa 25.000 U.F. Eur Cp 1000020757

CLT Ref No.:  115940616

Deadline:  07 Apr 2025

Active Substance Sorafenib or Lenvatinib 1000020848

CLT Ref No.:  115940610

Deadline:  08 Apr 2025

Brigatinib Orcoo Order Order Order Olictinib 1000020851

CLT Ref No.:  115940609

Deadline:  08 Apr 2025

Princ. Activo Enzalutamida O Abiraterona1000020850

CLT Ref No.:  115940608

Deadline:  08 Apr 2025

Transport Service for Health Centers

CLT Ref No.:  115828405

Deadline:  17 Mar 2025

Etanercept 25 Mg05 Ml Sol. Iny.Jrp 1000020733

CLT Ref No.:  115827493

Deadline:  17 Mar 2025

60 Ml 1000020778 60 Ml Ctap Bottle

CLT Ref No.:  115827491

Deadline:  17 Mar 2025

Dasatinib Cm Rec 1000020753

CLT Ref No.:  115825949

Deadline:  27 Mar 2025

Palociblib Active Principle Ribociclib the Abemaciclib 1000020842

CLT Ref No.:  115825551

Deadline:  04 Apr 2025

Osimertinib Cm Rec 1000020755

CLT Ref No.:  115825549

Deadline:  04 Apr 2025

  Chat with us